Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF VIETNAM ENDOTRACHEAL TUBE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL ENDOTRACHEAL TUBE MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 TOP TO BOTTOM ANALYSIS
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 VENDOR SHARE ANALYSIS
2.2.10 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.11 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL ENDOTRACHEAL TUBE MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTLE ANALYSIS
5.2 PORTER’S FIVE FORCES
6 REGULATORY SCENARIO
7 GLOBAL ENDOTRACHEAL TUBE MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 ARMORED/ RE-INFORCED TUBES
7.2.1 CUFFED
7.2.2 UNCUFFED
7.3 MICROLARYNGOSCOPY TUBE
7.3.1 CUFFED
7.3.2 UNCUFFED
7.4 PARKER FLEX-TIP TUBE
7.4.1 CUFFED
7.4.2 UNCUFFED
7.5 RAE TUBES
7.5.1 CUFFED
7.5.2 UNCUFFED
7.6 OTHERS
8 GLOBAL ENDOTRACHEAL TUBE MARKET, BY TYPE
8.1 OVERVIEW
8.2 CUFFED
8.3 UNCUFFED
9 GLOBAL ENDOTRACHEAL TUBE MARKET, BY ROUTE
9.1 OVERVIEW
9.2 OROTRACHEAL
9.3 NASOTRACHEAL
10 GLOBAL ENDOTRACHEAL TUBE MARKET, BY AGE GROUP
10.1 OVERVIEW
10.2 ADULT
10.3 PEDIATRIC
11 GLOBAL ENDOTRACHEAL TUBE MARKET, BY SIZE
11.1 OVERVIEW
11.2 2.0MM TO 3.5MM
11.3 4.0MM TO 6.5MM
11.4 7.0MM TO 7.5MM
11.5 8.0MM TO 9.0MM
12 GLOBAL ENDOTRACHEAL TUBE MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 EMERGENCY TREATMENT
12.3 ANESTHESIA THERAPY
12.4 POST SURGERY
12.5 RESPIRATORY THERAPY
12.6 OTHERS
13 GLOBAL ENDOTRACHEAL TUBE MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 AMBULATORY SURGICAL CENTERS(ASCS)
13.4 HOMECARE SETTINGS
13.5 OUTPATIENT CLINIC
13.6 PHYSICIAN’S OFFICE
13.7 MEDICAL TRANSPORTATION
13.8 LONG TERM ASSISTED CARE
13.9 REHABILITATION CENTER
14 GLOBAL ENDOTRACHEAL TUBE MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDER
14.3 RETAIL SALE
15 GLOBAL ENDOTRACHEAL TUBE MARKET, BY REGION
15.1 GLOBAL ENDOTRACHEAL TUBE MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
15.2 NORTH AMERICA
15.2.1 U.S.
15.2.2 CANADA
15.2.3 MEXICO
15.3 EUROPE
15.3.1 GERMANY
15.3.2 FRANCE
15.3.3 U.K.
15.3.4 ITALY
15.3.5 SPAIN
15.3.6 RUSSIA
15.3.7 TURKEY
15.3.8 BELGIUM
15.3.9 NETHERLANDS
15.3.10 SWITZERLAND
15.3.11 LUXEMBURG
15.3.12 REST OF EUROPE
15.4 ASIA-PACIFIC
15.4.1 JAPAN
15.4.2 CHINA
15.4.3 SOUTH KOREA
15.4.4 INDIA
15.4.5 AUSTRALIA
15.4.6 SINGAPORE
15.4.7 THAILAND
15.4.8 MALAYSIA
15.4.9 INDONESIA
15.4.10 PHILIPPINES
15.4.11 REST OF ASIA-PACIFIC
15.5 SOUTH AMERICA
15.5.1 BRAZIL
15.5.2 ARGENTINA
15.5.3 REST OF SOUTH AMERICA
15.6 MIDDLE EAST AND AFRICA
15.6.1 SOUTH AFRICA
15.6.2 SAUDI ARABIA
15.6.3 UAE
15.6.4 EGYPT
15.6.5 ISRAEL
15.6.6 REST OF MIDDLE EAST AND AFRICA
15.7 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
16 GLOBAL ENDOTRACHEAL TUBE MARKET, BY REGION
16.1 GLOBAL ENDOTRACHEAL TUBE MARKET, COMPANY LANDSCAPE
16.2 COMPANY SHARE ANALYSIS: GLOBAL
16.3 MERGERS & ACQUISITIONS
16.4 NEW PRODUCT DEVELOPMENT & APPROVALS
16.5 EXPANSIONS
16.6 REGULATORY CHANGES
16.7 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
17 GLOBAL ENDOTRACHEAL TUBE MARKET, COMPANY PROFILE
17.1 MEDTRONIC
17.1.1 COMPANY OVERVIEW
17.1.2 REVENUE ANALYSIS
17.1.3 GEOGRAPHIC PRESENCE
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENTS
17.2 TELEFLEX INCORPORATED
17.2.1 COMPANY OVERVIEW
17.2.2 REVENUE ANALYSIS
17.2.3 GEOGRAPHIC PRESENCE
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 INTERSURGICAL LTD
17.3.1 COMPANY OVERVIEW
17.3.2 REVENUE ANALYSIS
17.3.3 GEOGRAPHIC PRESENCE
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENTS
17.4 VYAIRE
17.4.1 COMPANY OVERVIEW
17.4.2 REVENUE ANALYSIS
17.4.3 GEOGRAPHIC PRESENCE
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 VYGON SA
17.5.1 COMPANY OVERVIEW
17.5.2 REVENUE ANALYSIS
17.5.3 GEOGRAPHIC PRESENCE
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENTS
17.6 VITALTEC CORPORATION
17.6.1 COMPANY OVERVIEW
17.6.2 REVENUE ANALYSIS
17.6.3 GEOGRAPHIC PRESENCE
17.6.4 PRODUCT PORTFOLIO
17.6.5 RECENT DEVELOPMENTS
17.7 FLEXICARE MEDICAL LIMITED.
17.7.1 COMPANY OVERVIEW
17.7.2 REVENUE ANALYSIS
17.7.3 GEOGRAPHIC PRESENCE
17.7.4 PRODUCT PORTFOLIO
17.7.5 RECENT DEVELOPMENTS
17.8 HUM GESELLSCHAFT FÜR HOMECARE UND MEDIZINTECHNIK GMBH
17.8.1 COMPANY OVERVIEW
17.8.2 REVENUE ANALYSIS
17.8.3 GEOGRAPHIC PRESENCE
17.8.4 PRODUCT PORTFOLIO
17.8.5 RECENT DEVELOPMENTS
17.9 AVANOS CORPORATE
17.9.1 COMPANY OVERVIEW
17.9.2 REVENUE ANALYSIS
17.9.3 GEOGRAPHIC PRESENCE
17.9.4 PRODUCT PORTFOLIO
17.9.5 RECENT DEVELOPMENTS
17.1 BD
17.10.1 COMPANY OVERVIEW
17.10.2 REVENUE ANALYSIS
17.10.3 GEOGRAPHIC PRESENCE
17.10.4 PRODUCT PORTFOLIO
17.10.5 RECENT DEVELOPMENTS
17.11 OSCAR BOSCAROL S.R.L.
17.11.1 COMPANY OVERVIEW
17.11.2 REVENUE ANALYSIS
17.11.3 GEOGRAPHIC PRESENCE
17.11.4 PRODUCT PORTFOLIO
17.11.5 RECENT DEVELOPMENTS
17.12 ATPL
17.12.1 COMPANY OVERVIEW
17.12.2 REVENUE ANALYSIS
17.12.3 GEOGRAPHIC PRESENCE
17.12.4 PRODUCT PORTFOLIO
17.12.5 RECENT DEVELOPMENTS
17.13 TROGE MEDICAL GMBH
17.13.1 COMPANY OVERVIEW
17.13.2 REVENUE ANALYSIS
17.13.3 GEOGRAPHIC PRESENCE
17.13.4 PRODUCT PORTFOLIO
17.13.5 RECENT DEVELOPMENTS
17.14 CARDIOMED SUPPLIES INC.
17.14.1 COMPANY OVERVIEW
17.14.2 REVENUE ANALYSIS
17.14.3 GEOGRAPHIC PRESENCE
17.14.4 PRODUCT PORTFOLIO
17.14.5 RECENT DEVELOPMENTS
17.15 STEVE SHANDONG MEDICAL SCIENCE & TECHNOLOGY CO.LTD.
17.15.1 COMPANY OVERVIEW
17.15.2 REVENUE ANALYSIS
17.15.3 GEOGRAPHIC PRESENCE
17.15.4 PRODUCT PORTFOLIO
17.15.5 RECENT DEVELOPMENTS
17.16 SMITHS MEDICAL
17.16.1 COMPANY OVERVIEW
17.16.2 REVENUE ANALYSIS
17.16.3 GEOGRAPHIC PRESENCE
17.16.4 PRODUCT PORTFOLIO
17.16.5 RECENT DEVELOPMENTS
17.17 B. BRAUN MELSUNGEN AG
17.17.1 COMPANY OVERVIEW
17.17.2 REVENUE ANALYSIS
17.17.3 GEOGRAPHIC PRESENCE
17.17.4 PRODUCT PORTFOLIO
17.17.5 RECENT DEVELOPMENTS
17.18 FUJI SYSTEMS
17.18.1 COMPANY OVERVIEW
17.18.2 REVENUE ANALYSIS
17.18.3 GEOGRAPHIC PRESENCE
17.18.4 PRODUCT PORTFOLIO
17.18.5 RECENT DEVELOPMENTS
17.19 ROYAX
17.19.1 COMPANY OVERVIEW
17.19.2 REVENUE ANALYSIS
17.19.3 GEOGRAPHIC PRESENCE
17.19.4 PRODUCT PORTFOLIO
17.19.5 RECENT DEVELOPMENTS
17.2 CONVATEC GROUP PLC
17.20.1 COMPANY OVERVIEW
17.20.2 REVENUE ANALYSIS
17.20.3 GEOGRAPHIC PRESENCE
17.20.4 PRODUCT PORTFOLIO
17.20.5 RECENT DEVELOPMENTS
17.21 KARL STORZ
17.21.1 COMPANY OVERVIEW
17.21.2 REVENUE ANALYSIS
17.21.3 GEOGRAPHIC PRESENCE
17.21.4 PRODUCT PORTFOLIO
17.21.5 RECENT DEVELOPMENTS
17.22 INTERSURGICAL LTD.
17.22.1 COMPANY OVERVIEW
17.22.2 REVENUE ANALYSIS
17.22.3 GEOGRAPHIC PRESENCE
17.22.4 PRODUCT PORTFOLIO
17.22.5 RECENT DEVELOPMENTS
17.23 SUNMED LLC
17.23.1 COMPANY OVERVIEW
17.23.2 REVENUE ANALYSIS
17.23.3 GEOGRAPHIC PRESENCE
17.23.4 PRODUCT PORTFOLIO
17.23.5 RECENT DEVELOPMENTS
17.24 VBM MEDIZINTECHNIK
17.24.1 COMPANY OVERVIEW
17.24.2 REVENUE ANALYSIS
17.24.3 GEOGRAPHIC PRESENCE
17.24.4 PRODUCT PORTFOLIO
17.24.5 RECENT DEVELOPMENTS
17.25 VERATHON
17.25.1 COMPANY OVERVIEW
17.25.2 REVENUE ANALYSIS
17.25.3 GEOGRAPHIC PRESENCE
17.25.4 PRODUCT PORTFOLIO
17.25.5 RECENT DEVELOPMENTS
17.26 SOURCEMARK
17.26.1 COMPANY OVERVIEW
17.26.2 REVENUE ANALYSIS
17.26.3 GEOGRAPHIC PRESENCE
17.26.4 PRODUCT PORTFOLIO
17.26.5 RECENT DEVELOPMENTS
17.27 MERCURY ENTERPRISES
17.27.1 COMPANY OVERVIEW
17.27.2 REVENUE ANALYSIS
17.27.3 GEOGRAPHIC PRESENCE
17.27.4 PRODUCT PORTFOLIO
17.27.5 RECENT DEVELOPMENTS
17.28 TRACOE MEDICAL
17.28.1 COMPANY OVERVIEW
17.28.2 REVENUE ANALYSIS
17.28.3 GEOGRAPHIC PRESENCE
17.28.4 PRODUCT PORTFOLIO
17.28.5 RECENT DEVELOPMENTS
18 RELATED REPORTS
19 QUESTIONNAIRE
20 CONCLUSION
21 ABOUT DATA BRIDGE MARKET RESEARCH
